Victoza and Thyroid Cancer: What You Should Know

You may have heard that celebrity chef and cook book author Paula Deen will be promoting the drug Victoza. Victoza is a brand name for the drug liraglutide. This medication was approved by the FDA in January 2010 for the treatment of type 2 diabetes.

During the approval process, the FDA raised questions about the safety of Victoza. Victoza is very similar to another diabetes drug, Byetta. Byetta has been linked to thyroid cancer.

In fact, the FDA determined that Victoza does significantly increase the risk of thyroid cancer in rodents. But, the drug was approved because researchers were unable to show a statistically significant risk to humans. In clinical trials, four patients developed thyroid cancer. Instead of banning the drug, the FDA required a “black box” label warning that those with a family history of thyroid cancer should not take the drug.

A “black box” label was also issued warning of a risk to those with a history of pancreatitis. Seven of the patients participating in clinical trials developed pancreatitis.

Clinical trials take about five years. Diabetes lasts a lifetime. Unfortunately, many of the effects of dangerous drugs develop after long-term exposure.

If you are taking Victoza, you should be aware of the signs of Victoza thyroid cancer and pancreatitis. Signs of thyroid cancer include a mass in the neck, difficulty swallowing, hoarseness and shortness of breath. Signs of pancreatitis include persistent, severe abdominal pain, and, possibly, vomiting. Acute pancreatitis can cause organ damage and even death.

Why are dangerous drugs available to the public? Dallas drug injury attorney Kay Van Wey explains in her book, 7 Secrets the Pharmaceutical Industry Does NOT Want You to Know. Request your free copy.

To discuss a Victoza thyroid cancer or pancreatitis injury claim, contact Van Wey Law at 800-489-5082.